Unlock Cancer Treatment Potential with 6,7-Bis(2-methoxyethoxy)-4(3H)-quinazolinone

Discover the high-purity chemical intermediate essential for synthesizing Erlotinib, a vital tyrosine kinase inhibitor. Explore its properties, applications, and benefits for pharmaceutical manufacturing.

Get a Quote & Sample

Benefits of Choosing Our Intermediate

Exceptional Purity for Efficacy

Achieve superior drug synthesis outcomes with our 6,7-Bis(2-methoxyethoxy)-4(3H)-quinazolinone, offering a purity level of ≥99.0% essential for the efficacy of Erlotinib.

Trusted Chinese Manufacturer

Leverage our expertise as a reliable manufacturer in China. We ensure consistent supply and quality for your pharmaceutical intermediates, including the critical Erlotinib intermediate.

Consistent Product Specifications

Benefit from reliable physical and chemical properties, including its white solid form and defined melting point, simplifying integration into your pharmaceutical synthesis workflows.

Key Applications

Erlotinib Synthesis

This compound serves as a fundamental building block for the production of Erlotinib, a vital targeted therapy for certain types of cancer, underscoring its importance in the pharmaceutical supply chain.

Pharmaceutical Intermediate Manufacturing

Used extensively in the manufacturing of active pharmaceutical ingredients (APIs), this high-purity intermediate is crucial for creating complex drug molecules like Erlotinib, ensuring product integrity.

Chemical Research and Development

Researchers and chemists utilize this compound in R&D for developing new synthetic routes and exploring novel therapeutic agents, making it a valuable tool in the field of medicinal chemistry.

Oncology Drug Development

As a direct precursor to an established cancer drug, this intermediate plays a critical role in the ongoing development and production of oncology treatments, supporting the fight against cancer.